Press review archive 2021
On this page, you can find all the press review of 2021
2021 – June 26
Business Wire
Italfarmaco Announces Topline Data from Phase 2 Trial with Givinostat in Patients with Becker Muscular Dystrophy
2021 – March 16
ITALFARMACO
Italfarmaco Group adds innovative Alzheimer’s disease therapy to its neurology-based product portfolio
2021 – February 22
Business Wire
Italfarmaco provides an update on the clinical development program of Givinostat in Duchenne Muscular Dystrophy